# Frontida BioPharm Inc – FDA Inspection, Dec 7, 2023

Source: https://www.keypedia.com/records/fda_inspections/frontida-biopharm-inc/9b8055f0-3548-413c-a40b-5814226a9434
Source feed: FDA_Inspections

> FDA inspection 1226606 of Frontida BioPharm Inc, December 07, 2023. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR parts 211 and 314. Form 483 issued. 14 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1226606
- Company Name: Frontida BioPharm Inc
- Inspection Date: 2023-12-07
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1316756 - 2026-04-02
- FDA Inspection 1280570 - 2025-07-22
- [FDA Inspection 1279864 - 2025-07-22](https://www.keypedia.com/records/fda_inspections/frontida-biopharm-inc/be6ada2f-716c-4ddd-8b36-f7d3b7cd65b3)
- [FDA Inspection 1097023 - 2019-07-19](https://www.keypedia.com/records/fda_inspections/frontida-biopharm-inc/19fa9164-4fb0-41e4-9013-e9731116e4ad)
- FDA Inspection 1030391 - 2017-07-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)

Company: https://www.keypedia.com/companies/frontida-biopharm-inc/dc8190f9-0e13-4160-a611-dcf664f43b09

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c